Low HLA-A expression linked to NK cell phenotype and functionality is associated with low total HIV-1 DNA and cure/remission in very early art-treated children
Natural killer (NK) cells play a central role in immune control of HIV-1 in ART-naïve children and also in post-treatment control in adults living with HIV-1. To evaluate the role of NK cell activity in post-treatment control in very early-ART-treated children, we here studied a cohort of 274 children from KwaZulu-Natal followed from birth after vertical transmission. Baseline/birth total HIV-1 DNA load was associated with time to achieve undetectable HIV-1 DNA load on ART, and with achievement of sustained ART-free aviraemia following unscheduled treatment interruption in 5 previously-reported males. Low HLA-A expression was associated with low total HIV-1 DNA load at baseline. At 9m age in virally-suppressed children, low total HIV-1 DNA was associated with low HLA-A expression, with high expression of NKG2D on CD56 dim cells and with high expression of CD107a on CD56 dim cells. Despite broadly stronger NK responses in female infants compared to males, total HIV-1 DNA loads were typically higher in females, notably in females expressing ‘protective’ HLA-B*57/58:01/81:01 molecules, in whom proteomic analysis demonstrated upregulation of the pro-inflammatory IL-17 pathway. Together, these data indicate a central role for specific NK responses in HIV-1 cure/remission following very-early ART in children LWH, consistent with studies of post-treatment control in adults LWH.
Authors
- Mary N Carrington (ORCID: https://orcid.org/0000-0002-2692-2180)
- Maria Carmen Puertas (ORCID: https://orcid.org/0000-0002-6750-2318)
- Nicholas G. Herbert (ORCID: https://orcid.org/0000-0002-3708-694X)
- Paolo Palma (ORCID: https://orcid.org/0000-0002-3066-4719)
- Gabriela Cromhout (ORCID: https://orcid.org/0000-0003-2748-1572)
- Maria C. García-Guerrero (ORCID: https://orcid.org/0000-0002-6750-2318)
- Giuseppe Rubens Pascucci (ORCID: https://orcid.org/0000-0002-5978-1193)
- Thumbi Ndung’u (ORCID: https://orcid.org/0000-0003-2962-3992)
- Philip Goulder (ORCID: https://orcid.org/0000-0002-9842-4674)
- Donato Amodio (ORCID: https://orcid.org/0000-0003-4550-3018)
- Wilfredo F. García-Beltrán (ORCID: https://orcid.org/0000-0002-7109-0504)
- Kogielambal Chinniah (ORCID: https://orcid.org/0009-0006-3869-8071)
- Jeroen van Lobenstein
- Veron Ramsuran (ORCID: https://orcid.org/0000-0003-1590-9893)
- Noxolo Mchunu
- Roopesh Bhoola
- Javier Martínez‐Picado (ORCID: https://orcid.org/0000-0002-4916-2129)
- Dimitra Peppa (ORCID: https://orcid.org/0000-0002-9281-5471)
- Nomonde Bengu (ORCID: https://orcid.org/0009-0005-4694-8475)
- Nicola Cotugno (ORCID: https://orcid.org/0000-0002-7748-1581)
- Rowena Fillis
- Andreas Groll (ORCID: https://orcid.org/0000-0001-6787-9118)
- Samantha Kannie
- Malini Krishna (ORCID: https://orcid.org/0009-0004-9085-8939)
Institutions
- Universitat de Vic - Universitat Central de Catalunya (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Harvard University (US)
- TU Dortmund University (DE)
- Instituto de Salud Carlos III (ES)
- University of Oxford (GB)
- IrsiCaixa (ES)
- Stanger Hospital (ZA)
- Queen Nandi Regional Hospital (ZA)
- Bambino Gesù Children's Hospital (IT)
- Africa Health Research Institute (ZA)
- Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES)
- Mahatma Gandhi Memorial Hospital (ZA)
- National Cancer Institute (US)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University College London (GB)
- Massachusetts Institute of Technology (US)
- University of KwaZulu-Natal (ZA)
Publication Details
- Journal
- PLoS Pathogens
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1371/journal.ppat.1014788
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00